Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir
Clinical trial NCT02945956 · UNKNOWN
Trial details
- NCT number
- NCT02945956
- Sponsor
- ShuGuang Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-05
- Primary completion
- 2020-06-01
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.